Scynexis BREXAFEMME (Ibrexafungerp) tablets 150 mg, 4 count cartons recall — FDA D-0042-2024
Cross Contamination with Other Products: Potential cross-contamination of ibrexafungerp citrate drug substance with ezetimibe (a non-antibacterial beta-lactam compound).